Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cibus, Inc.CLXT · Entity 6658 | Director | June 21, 2018 | June 25, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cibus, Inc.
Report date June 21, 2018 · Filed June 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,320 |
Reported balance
After 2018-06-21 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-06-21 · Sale · Disposed 5,880 · Balance 33,320 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.425, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3: Includes 33,320 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 5,880 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.425, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
F3: Includes 33,320 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 5,880 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2018 Filed Jun 25, 2018 18:57 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 5,880 | $20.84 | $122,540.38 |
DisclosureSEC source: 0001127602-18-021822 · form4.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,320 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.60 to $21.425, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 33,320 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 5,880 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · derivative · entry 9 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,300 Underlying: Common Stock · 10,000 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 10,000 | $19.00 | $190,000.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 6 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| March 12, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 10,000 | $3.59 | $35,878.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 5 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · derivative · entry 8 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,300 Underlying: Common Stock · 10,000 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 10,000 | $19.00 | $190,000.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 4 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 10,000 | $3.59 | $35,875.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 3 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · derivative · entry 7 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,300 Underlying: Common Stock · 10,000 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 10,000 | $19.00 | $190,000.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| March 05, 2018 Filed Mar 13, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 10,000 | $3.59 | $35,875.00 |
DisclosureSEC source: 0001127602-18-011458 · form4.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 10,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · derivative · entry 3 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,300 Underlying: Common Stock · 10,000 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 10,000 | $19.03 | $190,262.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.46, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:45 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 10,000 | $35.59 | $355,878.00 |
DisclosureSEC source: 0001615594-18-000016 · primary_doc.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 400 | $19.00 | $7,600.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 7 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 13,700 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · derivative · entry 9 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,300 Underlying: Common Stock · 13,700 shares Expires 2026-04-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 13,300 | $19.19 | $255,200.40 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 6 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,600 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.44, inclusive. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 13,700 | $3.58 | $49,046.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 5 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionStock Option (Right-to-Buy) · Derivative | 6,125 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · derivative · entry 8 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,125 shares Expires 2024-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 600 | $21.90 | $13,140.48 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 4 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.84-21.94, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 1,900 | $21.23 | $40,341.18 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 3 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.68, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 3,625 | $20.23 | $73,322.15 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 2 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77-20.76, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-5 to this Form 4. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 23:09 UTC | Cibus, Inc. CLXT · Entity 6658 | Exercise / conversionCommon Stock | 6,125 | $3.71 | $22,723.75 |
DisclosureSEC source: 0001615594-18-000015 · primary_doc.xml · nonDerivative · entry 1 Godard Alain · CIK 0001712102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.